Table 2.
Covariate | Hazard Ratio (95% CI) | P Value |
---|---|---|
Group A (relative to group B) | 0.31 (0.29 to 0.33) | <0.001 |
Age | 0.99 (0.99 to 1.00) | 0.001 |
Male sex | 1.43 (1.32 to 1.55) | <0.001 |
Dual‐chamber ICD (relative to single chamber) | 0.93 (0.86 to 1.01) | 0.088 |
CRT‐D (relative to single chamber) | 1.01 (0.93 to 1.10) | 0.743 |
Implant DFT performed | 0.31 (0.29 to 0.33) | 0.020 |
Group A (relative to group B) | 0.33 (0.31 to 0.36) | <0.001 |
Age | 0.99 (0.99 to 1.00) | <0.001 |
Male sex | 1.55 (1.40 to 1.73) | <0.001 |
Dual‐chamber ICD (relative to single chamber) | 0.84 (0.75 to 0.93) | 0.001 |
CRT‐D (relative to single chamber) | 0.94 (0.85 to 1.05) | 0.282 |
Implant DFT performed | 0.88 (0.80 to 0.96) | 0.006 |
bpm indicates beats per minute; CRT‐D, cardiac resynchronization therapy‐defibrillator; DFT, defibrillation threshold test; ICD, implantable cardioverter‐defibrillator.